These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34257047)

  • 1. Never too old for lipid-lowering therapy.
    Boccara F
    Arch Cardiovasc Dis; 2021; 114(8-9):524-526. PubMed ID: 34257047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statin and cardiovascular diseases after 75 years].
    Retornaz F; Beliard S; Gremeaux E; Chiche L; Lagarde L; Andrianasolo M; Molines C; Oliver C
    Rev Med Interne; 2016 Sep; 37(9):625-31. PubMed ID: 27389014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].
    Soska V
    Vnitr Lek; 2011 Mar; 57(3):313-6. PubMed ID: 21495414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The indication for lipid-lowering therapy and its intensity is based on the cardiovascular risk, not on the level of cholesterol].
    Parhofer KG
    MMW Fortschr Med; 2024 Mar; 166(5):52-53. PubMed ID: 38514561
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy with statins: who benefits?
    Singh A; Davidson M
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):993-1006. PubMed ID: 25432393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipid lowering therapy in geriatric patients].
    Lechleitner M
    Z Gerontol Geriatr; 2013 Aug; 46(6):577-85; quiz 586-7. PubMed ID: 23955359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-lowering agents and risk of melanoma.
    Kirsner RS; Ramirez CC; Federman DG; Ma F
    Int J Cancer; 2005 Nov; 117(2):333; author reply 334. PubMed ID: 15900582
    [No Abstract]   [Full Text] [Related]  

  • 8. Rhabdomyolysis and lipid-lowering drugs.
    Tenenbaum A; Fisman EZ; Motro M
    JAMA; 2005 Mar; 293(12):1448; author reply 1448-9. PubMed ID: 15784863
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrate and statine myopathy].
    Finsterer J
    Nervenarzt; 2003 Feb; 74(2):115-22. PubMed ID: 12596012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin intolerance: diagnosis and remedies.
    Pirillo A; Catapano AL
    Curr Cardiol Rep; 2015 May; 17(5):27. PubMed ID: 25894795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid lowering for secondary prevention of cardiovascular disease in older adults.
    Thomas JE; Tershakovec AM; Jones-Burton C; Sayeed RA; Foody JM
    Drugs Aging; 2010 Dec; 27(12):959-72. PubMed ID: 21087066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Lowering Therapy in the Elderly: Are Current Guidelines a Sign of Ageism in Medical Care?
    Ballantyne CM; Varughese MG; Abushamat LA
    J Am Coll Cardiol; 2023 Apr; 81(14):1350-1352. PubMed ID: 37019581
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of lipid-lowering agents (statins) during pregnancy.
    Hosokawa A; Bar-Oz B; Ito S
    Can Fam Physician; 2003 Jun; 49():747-9. PubMed ID: 12836860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-drug interactions and statin therapy.
    Trifiro G
    South Med J; 2006 Dec; 99(12):1325-6. PubMed ID: 17233186
    [No Abstract]   [Full Text] [Related]  

  • 15. [HMG-CoA reductase inhibitors (statin)].
    Yamamura T; Ishigami M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():458-64. PubMed ID: 17824071
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis.
    Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R
    Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstacles to Optimal Lipid-Lowering Therapy　- Any Solution?
    Kataoka Y
    Circ J; 2018 Mar; 82(4):948-950. PubMed ID: 29526987
    [No Abstract]   [Full Text] [Related]  

  • 18. Overcoming toxicity and side-effects of lipid-lowering therapies.
    Wilkinson MJ; Laffin LJ; Davidson MH
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):439-52. PubMed ID: 24840269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse effects of lipid-lowering medications].
    Fukumoto Y; Shimokawa H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():165-72. PubMed ID: 18074533
    [No Abstract]   [Full Text] [Related]  

  • 20. Limitations of a meta-analysis investigating the association between cancer and statin use.
    Iwata H; Aoyama T; Kusumi E; Hamaki T; Kami M
    Am J Med; 2002 Feb; 112(2):157-8. PubMed ID: 11835959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.